Caractérisation du mode de régulation du récepteur 2B de la sérotonine (HTR2B) dans le mélanome uvéal

Authors: Benhassine, Manel
Advisor: Guérin, Sylvain
Abstract: Uveal melanoma (UM) is the most common type of primary intraocular tumor in the adult population. UM will propagate to the liver as the first metastatic site. Once this organ is invaded, survival becomes a matter of months for the patient as no treatment has proven to be effective. Among the candidates from the class II gene signature, the serotonin receptor-encoding gene (HTR2B) appears to be the most discriminating as its expression strongly increases in the tumors that will progress toward liver metastases. Our study aims at characterizing the molecular mechanisms that lead to this aberrant expression of HTR2B in metastatic UM cell lines. Expression of HTR2B was monitered by microarrays in a variety of UM cell lines. Various segments from the promoter and 5’-flanking sequence of the HTR2B gene were cloned upstream the CAT gene in the plasmid pCATbasic. The genomic areas of interest were 5’end-labeled and used as probes in electrophoretic mobility shift assays (EMSAs). DMS methylation interference footprinting was also used to precisely position the DNA target sites for transcription factors (TFs) that bind the HTR2B regulatory regions. Transfection analyses revealed that the upstream regulatory regions of HTR2B promoter is made up of a combination of alternative positive and negative regulatory elements. Repressive regions also bear a high number of target sites for the TF NFI. EMSA analyses provided evidence that multiple NFI isoforms can interact with the promoter of the HTR2B gene. In addition, the TF RUNX1 was shown by DMS methylation interference footprinting to bind a target site from the HTR2B distal silencer element. This project will help understand better the molecular mechanisms accounting for the abnormal expression of HTR2B in uveal melanoma. In the long term, this study will allow us to identify new potential targets that could help screening patients at high risk of evolving toward the liver metastatic disease.
Document Type: Mémoire de maîtrise
Issue Date: 2017
Open Access Date: 5 July 2018
Permalink: http://hdl.handle.net/20.500.11794/30257
Grantor: Université Laval
Collection:Thèses et mémoires

Files in this item:
Description SizeFormat 
33387.pdf3.68 MBAdobe PDFThumbnail
View/Open
All documents in CorpusUL are protected by Copyright Act of Canada.